225 related articles for article (PubMed ID: 9173883)
21. Modulation of Human Arylamine
Butcher NJ; Burow R; Minchin RF
Mol Pharmacol; 2020 Aug; 98(2):88-95. PubMed ID: 32487734
[TBL] [Abstract][Full Text] [Related]
22. The Bacillus anthracis arylamine N-acetyltransferase ((BACAN)NAT1) that inactivates sulfamethoxazole, reveals unusual structural features compared with the other NAT isoenzymes.
Pluvinage B; Li de la Sierra-Gallay I; Kubiak X; Xu X; Dairou J; Dupret JM; Rodrigues-Lima F
FEBS Lett; 2011 Dec; 585(24):3947-52. PubMed ID: 22062153
[TBL] [Abstract][Full Text] [Related]
23. Longitudinal distribution of arylamine N-acetyltransferases in the intestine of the hamster, mouse, and rat. Evidence for multiplicity of N-acetyltransferases in the intestine.
Ware JA; Svensson CK
Biochem Pharmacol; 1996 Nov; 52(10):1613-20. PubMed ID: 8937477
[TBL] [Abstract][Full Text] [Related]
24. 3D model of human arylamine N-acetyltransferase 2: structural basis of the slow acetylator phenotype of the R64Q variant and analysis of the active-site loop.
Rodrigues-Lima F; Dupret JM
Biochem Biophys Res Commun; 2002 Feb; 291(1):116-23. PubMed ID: 11829470
[TBL] [Abstract][Full Text] [Related]
25. Structure and regulation of the drug-metabolizing enzymes arylamine N-acetyltransferases.
Dupret JM; Rodrigues-Lima F
Curr Med Chem; 2005; 12(3):311-8. PubMed ID: 15723621
[TBL] [Abstract][Full Text] [Related]
26. Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice.
Sugamori KS; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM
Mol Pharmacol; 2003 Jul; 64(1):170-9. PubMed ID: 12815173
[TBL] [Abstract][Full Text] [Related]
27. Genetic variants of N-acetyltransferases 1 and 2 (NAT1 and NAT2) in cynomolgus and rhesus macaques.
Uno Y; Murayama N; Yamazaki H
Biochem Pharmacol; 2020 Jul; 177():113996. PubMed ID: 32339492
[TBL] [Abstract][Full Text] [Related]
28. Structural basis of substrate-binding specificity of human arylamine N-acetyltransferases.
Wu H; Dombrovsky L; Tempel W; Martin F; Loppnau P; Goodfellow GH; Grant DM; Plotnikov AN
J Biol Chem; 2007 Oct; 282(41):30189-97. PubMed ID: 17656365
[TBL] [Abstract][Full Text] [Related]
29. Arylamine N-acetyltransferase aggregation and constitutive ubiquitylation.
Liu F; Zhang N; Zhou X; Hanna PE; Wagner CR; Koepp DM; Walters KJ
J Mol Biol; 2006 Aug; 361(3):482-92. PubMed ID: 16857211
[TBL] [Abstract][Full Text] [Related]
30. Chemical modification of hamster arylamine N-acetyltransferase 2 with isozyme-selective and nonselective N-arylbromoacetamido reagents.
Wang H; Guo Z; Vath GM; Wagner CR; Hanna PE
Protein J; 2004 Feb; 23(2):153-66. PubMed ID: 15106881
[TBL] [Abstract][Full Text] [Related]
31. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.
Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW
Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359
[TBL] [Abstract][Full Text] [Related]
32. Arylamine N-acetyltransferases: from structure to function.
Sim E; Walters K; Boukouvala S
Drug Metab Rev; 2008; 40(3):479-510. PubMed ID: 18642144
[TBL] [Abstract][Full Text] [Related]
33. Fusarium verticillioides NAT1 (FDB2) N-malonyltransferase is structurally, functionally and phylogenetically distinct from its N-acetyltransferase (NAT) homologues.
Karagianni EP; Kontomina E; Lowe ED; Athanasopoulos K; Papanikolaou G; Garefalaki V; Kotseli V; Zaliou S; Grimaud T; Arvaniti K; Tsatiri MA; Fakis G; Glenn AE; Roversi P; Abuhammad A; Ryan A; Sim RB; Sim E; Boukouvala S
FEBS J; 2023 May; 290(9):2412-2436. PubMed ID: 36178468
[TBL] [Abstract][Full Text] [Related]
34. Metabolic activation of N-hydroxyarylamines and N-hydroxyarylamides by 16 recombinant human NAT2 allozymes: effects of 7 specific NAT2 nucleic acid substitutions.
Hein DW; Doll MA; Rustan TD; Ferguson RJ
Cancer Res; 1995 Aug; 55(16):3531-6. PubMed ID: 7627960
[TBL] [Abstract][Full Text] [Related]
35. Human acetyltransferase polymorphisms.
Grant DM; Hughes NC; Janezic SA; Goodfellow GH; Chen HJ; Gaedigk A; Yu VL; Grewal R
Mutat Res; 1997 May; 376(1-2):61-70. PubMed ID: 9202739
[TBL] [Abstract][Full Text] [Related]
36. Human N-acetylation of benzidine: role of NAT1 and NAT2.
Zenser TV; Lakshmi VM; Rustan TD; Doll MA; Deitz AC; Davis BB; Hein DW
Cancer Res; 1996 Sep; 56(17):3941-7. PubMed ID: 8752161
[TBL] [Abstract][Full Text] [Related]
37. Arylamine N-acetyltransferase I.
Minchin RF; Hanna PE; Dupret JM; Wagner CR; Rodrigues-Lima F; Butcher NJ
Int J Biochem Cell Biol; 2007; 39(11):1999-2005. PubMed ID: 17392017
[TBL] [Abstract][Full Text] [Related]
38. Effect of arylamine acetyltransferase Nat3 gene knockout on N-acetylation in the mouse.
Sugamori KS; Brenneman D; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM
Drug Metab Dispos; 2007 Jul; 35(7):1064-70. PubMed ID: 17403913
[TBL] [Abstract][Full Text] [Related]
39. Structures of human arylamine N-acetyltransferases.
Grant DM
Curr Drug Metab; 2008 Jul; 9(6):465-70. PubMed ID: 18680466
[TBL] [Abstract][Full Text] [Related]
40. The Arylamine N-Acetyltransferases as Therapeutic Targets in Metabolic Diseases Associated with Mitochondrial Dysfunction.
Choudhury C; Gill MK; McAleese CE; Butcher NJ; Ngo ST; Steyn FJ; Minchin RF
Pharmacol Rev; 2024 Feb; 76(2):300-320. PubMed ID: 38351074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
